Targeting NF-κB-mediated inflammatory pathways in cisplatin-resistant NSCLC.
Ryan SL, Beard S, Barr MP, Umezawa K, Heavey S, Godwin P, Gray SG, Cormican D, Finn SP, Gately KA, Davies AM, Thompson EW, Richard DJ, O'Byrne KJ, Adams MN, Baird AM.
Ryan SL, et al. Among authors: cormican d.
Lung Cancer. 2019 Sep;135:217-227. doi: 10.1016/j.lungcan.2019.07.006. Epub 2019 Jul 12.
Lung Cancer. 2019.
PMID: 31446998